AMP Capital Investors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-47,753
| Closed | -$13.5M | – | 294 |
|
|
2021
Q3 | $13.5M | Sell |
47,753
-6,387
| -12% | -$2.09M | 0.07% | 291 |
|
|
2021
Q2 | $18.7M | Sell |
54,140
-12,955
| -19% | -$3.92M | 0.09% | 263 |
|
|
2021
Q1 | $18.7M | Sell |
67,095
-7,962
| -11% | -$2.15M | 0.09% | 253 |
|
|
2020
Q4 | $18.3M | Sell |
75,057
-20,714
| -22% | -$5.34M | 0.1% | 241 |
|
|
2020
Q3 | $27M | Sell |
95,771
-9,915
| -9% | -$2.77M | 0.16% | 145 |
|
|
2020
Q2 | $27.5M | Sell |
105,686
-24,141
| -19% | -$7.26M | 0.17% | 142 |
|
|
2020
Q1 | $41M | Sell |
129,827
-9,076
| -7% | -$2.75M | 0.3% | 79 |
|
|
2019
Q4 | $41.1M | Sell |
138,903
-18,283
| -12% | -$5.07M | 0.23% | 107 |
|
|
2019
Q3 | $36.2M | Sell |
157,186
-23,042
| -13% | -$5.37M | 0.2% | 120 |
|
|
2019
Q2 | $43.2M | Buy |
180,228
+570
| +0.3% | +$132K | 0.24% | 103 |
|
|
2019
Q1 | $41.8M | Buy |
179,658
+40,064
| +29% | +$12.6M | 0.24% | 109 |
|
|
2018
Q4 | $41M | Sell |
139,594
-1,518
| -1% | -$484K | 0.26% | 97 |
|
|
2018
Q3 | $50.2M | Sell |
141,112
-6,349
| -4% | -$2.19M | 0.27% | 85 |
|
|
2018
Q2 | $42.8M | Buy |
147,461
+17,540
| +14% | +$4.93M | 0.24% | 106 |
|
|
2018
Q1 | $35.3M | Buy |
129,921
+13,328
| +11% | +$4.14M | 0.2% | 131 |
|
|
2017
Q4 | $37.1M | Buy |
116,593
+16,952
| +17% | +$5.44M | 0.2% | 129 |
|
|
2017
Q3 | $31.2M | Sell |
99,641
-2,423
| -2% | -$717K | 0.18% | 143 |
|
|
2017
Q2 | $27.7M | Buy |
102,064
+4,557
| +5% | +$1.2M | 0.16% | 147 |
|
|
2017
Q1 | $26.2M | Buy |
97,507
+9,560
| +11% | +$2.7M | 0.16% | 163 |
|
|
2016
Q4 | $25.2M | Sell |
87,947
-5,708
| -6% | -$1.69M | 0.15% | 153 |
|
|
2016
Q3 | $28.6M | Buy |
93,655
+1,566
| +2% | +$464K | 0.18% | 133 |
|
|
2016
Q2 | $22M | Buy |
92,089
+6,861
| +8% | +$1.81M | 0.15% | 163 |
|
|
2016
Q1 | $21.7M | Sell |
85,228
-33,551
| -28% | -$8.86M | 0.14% | 162 |
|
|
2015
Q4 | $36.6M | Sell |
118,779
-21,315
| -15% | -$6.12M | 0.25% | 93 |
|
|
2015
Q3 | $39M | Buy |
140,094
+8,284
| +6% | +$2.74M | 0.28% | 84 |
|
|
2015
Q2 | $52.2M | Sell |
131,810
-848
| -0.6% | -$340K | 0.34% | 77 |
|
|
2015
Q1 | $57.3M | Sell |
132,658
-19,107
| -13% | -$7.53M | 0.35% | 75 |
|
|
2014
Q4 | $51.9M | Sell |
151,765
-26,014
| -15% | -$8.42M | 0.32% | 79 |
|
|
2014
Q3 | $58.7M | Buy |
177,779
+21,951
| +14% | +$7.24M | 0.37% | 69 |
|
|
2014
Q2 | $49.6M | Sell |
155,828
-30,715
| -16% | -$9.24M | 0.31% | 80 |
|
|
2014
Q1 | $54.9M | Buy |
186,543
+23,154
| +14% | +$7.35M | 0.37% | 63 |
|
|
2013
Q4 | $45.7M | Buy |
163,389
+6,696
| +4% | +$1.73M | 0.32% | 70 |
|
|
2013
Q3 | $38.4M | Buy |
156,693
+39,729
| +34% | +$8.89M | 0.29% | 77 |
|
|
2013
Q2 | $24.4M | Buy |
+116,964
| New | +$25M | 0.19% | 119 |
|
Other funds holding BIIB
AMP Capital Investors's BIIB Position: Q4 2021 in Review
AMP Capital Investors sold out of Biogen (BIIB) in Q4 2021, closing a stake of 47,753 shares — an estimated $13.5M sold.
AMP Capital Investors first reported a position in BIIB in Q2 2013 and held it in 34 quarters. The position peaked at $58.7M in Q3 2014. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.
- AMP Capital Investors reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
- AMP Capital Investors sold 47,753 Biogen shares in Q4 2021, an estimated $13.5M.
- AMP Capital Investors first reported a position in Biogen in Q2 2013 and held it in 34 quarters.
- AMP Capital Investors's Biogen position peaked at $58.7M in Q3 2014.
- 1,010 funds tracked by Wall St. Rank held Biogen as of Q4 2021.
Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.